LANTERN PHARMA INC. +17.19% Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer with Drug Candidate LP-184

Press/Media

Period	Jul 20 2021

Media coverage

Title	LANTERN PHARMA INC. +17.19% Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer with Drug Candidate LP-184
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	07/20/21
URL	https://www.marketscreener.com/quote/stock/LANTERN-PHARMA-INC-108225202/news/Lantern-Pharma-Announces-Significant-Positive-Preclinical-Data-in-Pancreatic-Cancer-with-Drug-Candid-35909150/
Persons	Igor Astsaturov